A citation-based method for searching scientific literature

Abbas E Kitabchi, Guillermo E Umpierrez, John M Miles, Joseph N Fisher. Diabetes Care 2009
Times Cited: 542







List of co-cited articles
588 articles co-cited >1



Times Cited
Times     Co-cited
Similarity


Trends in Diabetic Ketoacidosis Hospitalizations and In-Hospital Mortality - United States, 2000-2014.
Stephen R Benoit, Yan Zhang, Linda S Geiss, Edward W Gregg, Ann Albright. MMWR Morb. Mortal. Wkly. Rep. 2018
44
34

Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia.
Guillermo Umpierrez, Mary Korytkowski. Nat Rev Endocrinol 2016
85
16


Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis.
M W Savage, K K Dhatariya, A Kilvert, G Rayman, J A E Rees, C H Courtney, L Hilton, P H Dyer, M S Hamersley. Diabet. Med. 2011
107
12

Euglycaemic diabetic ketoacidosis.
J F Munro, I W Campbell, A C McCuish, L J Duncan. Br Med J 1973
102
11

Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State.
Maya Fayfman, Francisco J Pasquel, Guillermo E Umpierrez. Med. Clin. North Am. 2017
22
45

Recurrent diabetic ketoacidosis in inner-city minority patients: behavioral, socioeconomic, and psychosocial factors.
Lori Randall, Jovan Begovic, Megan Hudson, Dawn Smiley, Limin Peng, Njalalia Pitre, Denise Umpierrez, Guillermo Umpierrez. Diabetes Care 2011
71
14


SGLT2 Inhibitors May Predispose to Ketoacidosis.
Simeon I Taylor, Jenny E Blau, Kristina I Rother. J. Clin. Endocrinol. Metab. 2015
205
10

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N. Engl. J. Med. 2015
10

Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition.
Anne L Peters, Elizabeth O Buschur, John B Buse, Pejman Cohan, Jamie C Diner, Irl B Hirsch. Diabetes Care 2015
323
9


Euglycemic Diabetic Ketoacidosis: A Review.
Anar Modi, Abhinav Agrawal, Farah Morgan. Curr Diabetes Rev 2017
35
25

Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis.
Carlos A Andrade-Castellanos, Luis Enrique Colunga-Lozano, Netzahualpilli Delgado-Figueroa, Daniel A Gonzalez-Padilla. Cochrane Database Syst Rev 2016
17
47

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS.
Yehuda Handelsman, Robert R Henry, Zachary T Bloomgarden, Sam Dagogo-Jack, Ralph A DeFronzo, Daniel Einhorn, Ele Ferrannini, Vivian A Fonseca, Alan J Garber, George Grunberger,[...]. Endocr Pract 2016
120
8

Health Care Utilization and Burden of Diabetic Ketoacidosis in the U.S. Over the Past Decade: A Nationwide Analysis.
Dimpi Desai, Dhruv Mehta, Priyanka Mathias, Gopal Menon, Ulrich K Schubart. Diabetes Care 2018
23
34

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N. Engl. J. Med. 2017
8



Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Melanie J Davies, David A D'Alessio, Judith Fradkin, Walter N Kernan, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Apostolos Tsapas, Deborah J Wexler, John B Buse. Diabetes Care 2018
531
7

Electrolyte and Acid-Base Disturbances in Patients with Diabetes Mellitus.
Biff F Palmer, Deborah J Clegg. N. Engl. J. Med. 2015
62
11

Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics.
N Glaser, P Barnett, I McCaslin, D Nelson, J Trainor, J Louie, F Kaufman, K Quayle, M Roback, R Malley,[...]. N. Engl. J. Med. 2001
346
7

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
D M Nathan, S Genuth, J Lachin, P Cleary, O Crofford, M Davis, L Rand, C Siebert. N. Engl. J. Med. 1993
7


Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia.
Elisa Hsia, Stacey Seggelke, Joanna Gibbs, R Matthew Hawkins, Elizabeth Cohlmia, Neda Rasouli, Cecilia Wang, Igal Kam, Boris Draznin. J. Clin. Endocrinol. Metab. 2012
38
18

Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.
Guillermo E Umpierrez, Kashif Latif, James Stoever, Ruben Cuervo, Linda Park, Amado X Freire, Abbas E Kitabchi. Am. J. Med. 2004
94
7

Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program.
Ngozi Erondu, Mehul Desai, Kirk Ways, Gary Meininger. Diabetes Care 2015
160
7

ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state.
Joseph I Wolfsdorf, Nicole Glaser, Michael Agus, Maria Fritsch, Ragnar Hanas, Arleta Rewers, Mark A Sperling, Ethel Codner. Pediatr Diabetes 2018
55
12

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study.
Paresh Dandona, Chantal Mathieu, Moshe Phillip, Lars Hansen, Diethelm Tschöpe, Fredrik Thorén, John Xu, Anna Maria Langkilde. Diabetes Care 2018
47
14

National survey of the management of Diabetic Ketoacidosis (DKA) in the UK in 2014.
K K Dhatariya, I Nunney, K Higgins, M J Sampson, G Iceton. Diabet. Med. 2016
34
17


Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state.
Abbas E Kitabchi, Guillermo E Umpierrez, Joseph N Fisher, Mary Beth Murphy, Frankie B Stentz. J. Clin. Endocrinol. Metab. 2008
70
8


Diabetic ketoacidosis: risk factors and management strategies.
Guillermo E Umpierrez, Abbas E Kitabchi. Treat Endocrinol 2003
71
8

Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data.
Jenny E Blau, Sri Harsha Tella, Simeon I Taylor, Kristina I Rother. Diabetes Metab. Res. Rev. 2017
41
14

SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature.
Kelly R Burke, Christine A Schumacher, Spencer E Harpe. Pharmacotherapy 2017
55
10

Is a priming dose of insulin necessary in a low-dose insulin protocol for the treatment of diabetic ketoacidosis?
Abbas E Kitabchi, Mary Beth Murphy, Judy Spencer, Robert Matteri, Jim Karas. Diabetes Care 2008
31
19

An Evaluation of Recurrent Diabetic Ketoacidosis, Fragmentation of Care, and Mortality Across Chicago, Illinois.
James A Mays, Kathryn L Jackson, Teresa A Derby, Jess J Behrens, Satyender Goel, Mark E Molitch, Abel N Kho, Amisha Wallia. Diabetes Care 2016
21
28

Increasing Hospitalizations for DKA: A Need for Prevention Programs.
Priyathama Vellanki, Guillermo E Umpierrez. Diabetes Care 2018
9
66

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial.
Chantal Mathieu, Paresh Dandona, Pieter Gillard, Peter Senior, Christoph Hasslacher, Eiichi Araki, Marcus Lind, Stephen C Bain, Serge Jabbour, Niki Arya,[...]. Diabetes Care 2018
71
8

Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials.
Julio Rosenstock, Jan Marquard, Lori M Laffel, Dietmar Neubacher, Stefan Kaspers, David Z Cherney, Bernard Zinman, Jay S Skyler, Jyothis George, Nima Soleymanlou,[...]. Diabetes Care 2018
66
9

Clinical Trial of Fluid Infusion Rates for Pediatric Diabetic Ketoacidosis.
Nathan Kuppermann, Simona Ghetti, Jeff E Schunk, Michael J Stoner, Arleta Rewers, Julie K McManemy, Sage R Myers, Lise E Nigrovic, Aris Garro, Kathleen M Brown,[...]. N. Engl. J. Med. 2018
26
23

Characteristics and outcomes of the hyperglycemic hyperosmolar non-ketotic syndrome in a cohort of 51 consecutive cases at a single center.
Gian Paolo Fadini, Saula Vigili de Kreutzenberg, Mauro Rigato, Stefano Brocco, Maria Marchesan, Antonio Tiengo, Angelo Avogaro. Diabetes Res. Clin. Pract. 2011
22
27

Management of hyperglycemic crises in patients with diabetes.
A E Kitabchi, G E Umpierrez, M B Murphy, E J Barrett, R A Kreisberg, J I Malone, B M Wall. Diabetes Care 2001
244
6

American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.
Etie S Moghissi, Mary T Korytkowski, Monica DiNardo, Daniel Einhorn, Richard Hellman, Irl B Hirsch, Silvio E Inzucchi, Faramarz Ismail-Beigi, M Sue Kirkman, Guillermo E Umpierrez. Diabetes Care 2009
603
5

Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review.
Soulmaz Fazeli Farsani, Kimberly Brodovicz, Nima Soleymanlou, Jan Marquard, Erika Wissinger, Brett A Maiese. BMJ Open 2017
35
14


Intensive versus conventional glucose control in critically ill patients.
Simon Finfer, Dean R Chittock, Steve Yu-Shuo Su, Deborah Blair, Denise Foster, Vinay Dhingra, Rinaldo Bellomo, Deborah Cook, Peter Dodek, William R Henderson,[...]. N. Engl. J. Med. 2009
5

Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion.
Caroline Bonner, Julie Kerr-Conte, Valéry Gmyr, Gurvan Queniat, Ericka Moerman, Julien Thévenet, Cédric Beaucamps, Nathalie Delalleau, Iuliana Popescu, Willy J Malaisse,[...]. Nat. Med. 2015
284
5



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.